Literature DB >> 27045383

Deep sequencing of hepatitis C virus reveals genetic compartmentalization in cerebrospinal fluid from cognitively impaired patients.

Damien C Tully1, Simon Hjerrild2,3, Peter D Leutscher2, Signe G Renvillard2, Colin B Ogilvie1, David J Bean1, Poul Videbech2,3, Todd M Allen1, Jane A McKeating4, Nicola F Fletcher5,6.   

Abstract

BACKGROUND & AIMS: Hepatitis C virus (HCV) causes neuropsychiatric impairment and fatigue with recent studies suggesting HCV invasion of the central nervous system (CNS). Our previous finding that endothelial cells from the blood-brain barrier support HCV infection warrants further investigation to elucidate whether the CNS can serve as a reservoir for independent HCV evolution.
METHODS: Cerebrospinal fluid (CSF) and plasma from six HCV-infected patients without liver disease or co-morbidities together with plasma from six healthy subjects were profiled for markers of immune activation and viral quasispecies measured by deep sequencing. Unsupervised data analyses were used to identify any associations between cytokine activation markers and clinical outcomes.
RESULTS: Four of six HCV-infected patients showed significant evidence of cognitive dysfunction and fatigue. Deep sequencing revealed independent viral evolution within the CNS of two cognitively impaired patients. Principal component analysis of peripheral cytokines demonstrated that individuals without cognitive impairment clustered together while a distinct cytokine pattern emerged with patients exhibiting cognitive dysfunction and fatigue.
CONCLUSIONS: Deep sequencing demonstrated unique viral variants in the CSF of two cognitively impaired patients consistent with CNS replication or sequestration. Meanwhile, compartmentalization was absent in infected patients with no neurocognitive impairment. Examination of cytokine profiles in HCV-infected patients with cognitive dysfunction revealed elevated peripheral cytokine levels resulting in a distinct cytokine profile that may be related to cognitive impairment or viral penetration into the CNS. Further studies to determine the significance of unique HCV variants within the CNS are warranted.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  brain; cytokine; hepatitis C virus; inflammation; quasispecies

Mesh:

Substances:

Year:  2016        PMID: 27045383      PMCID: PMC5553127          DOI: 10.1111/liv.13134

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  20 in total

1.  A statistical test for detecting geographic subdivision.

Authors:  R R Hudson; D D Boos; N L Kaplan
Journal:  Mol Biol Evol       Date:  1992-01       Impact factor: 16.240

2.  A cladistic measure of gene flow inferred from the phylogenies of alleles.

Authors:  M Slatkin; W P Maddison
Journal:  Genetics       Date:  1989-11       Impact factor: 4.562

3.  Fatigue in the general population: a translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale.

Authors:  Anners Lerdal; Astrid Wahl; Tone Rustøen; Berit R Hanestad; Torbjørn Moum
Journal:  Scand J Public Health       Date:  2005       Impact factor: 3.021

4.  Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis.

Authors:  Takaaki Ishizu; Manabu Osoegawa; Feng-Jun Mei; Hitoshi Kikuchi; Masahito Tanaka; Yuka Takakura; Motozumi Minohara; Hiroyuki Murai; Futoshi Mihara; Takayuki Taniwaki; Jun-ichi Kira
Journal:  Brain       Date:  2005-03-02       Impact factor: 13.501

5.  Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants.

Authors:  Daniel M Forton; Peter Karayiannis; Nadiya Mahmud; Simon D Taylor-Robinson; Howard C Thomas
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

6.  Molecular and bioinformatic evidence of hepatitis C virus evolution in brain.

Authors:  Sarah L Fishman; Jacinta M Murray; Francis J Eng; José L Walewski; Susan Morgello; Andrea D Branch
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

Review 7.  Drug-drug interactions during antiviral therapy for chronic hepatitis C.

Authors:  Jennifer J Kiser; James R Burton; Gregory T Everson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-02       Impact factor: 46.802

8.  Hepatitis C virus infects the endothelial cells of the blood-brain barrier.

Authors:  Nicola F Fletcher; Garrick K Wilson; Jacinta Murray; Ke Hu; Andrew Lewis; Gary M Reynolds; Zania Stamataki; Luke W Meredith; Ian A Rowe; Guangxiang Luo; Miguel A Lopez-Ramirez; Thomas F Baumert; Babette Weksler; Pierre-Olivier Couraud; Kwang Sik Kim; Ignacio A Romero; Catherine Jopling; Susan Morgello; Peter Balfe; Jane A McKeating
Journal:  Gastroenterology       Date:  2011-12-01       Impact factor: 22.682

9.  De novo assembly of highly diverse viral populations.

Authors:  Xiao Yang; Patrick Charlebois; Sante Gnerre; Matthew G Coole; Niall J Lennon; Joshua Z Levin; James Qu; Elizabeth M Ryan; Michael C Zody; Matthew R Henn
Journal:  BMC Genomics       Date:  2012-09-13       Impact factor: 3.969

10.  Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia.

Authors:  Gretja Schnell; Serena Spudich; Patrick Harrington; Richard W Price; Ronald Swanstrom
Journal:  PLoS Pathog       Date:  2009-04-24       Impact factor: 6.823

View more
  10 in total

1.  Interferon-free therapy in hepatitis C virus (HCV) monoinfected and HCV/HIV coinfected patients: effect on cognitive function, fatigue, and mental health.

Authors:  Felix Kleefeld; Sophie Heller; Patrick Ingiliz; Heiko Jessen; Anders Petersen; Ute Kopp; Antje Kraft; Katrin Hahn
Journal:  J Neurovirol       Date:  2018-05-21       Impact factor: 2.643

2.  Time course of cellular HIV-DNA and low-level HIV viremia in HIV-HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals.

Authors:  Saverio G Parisi; Samantha Andreis; Monica Basso; Silvia Cavinato; Renzo Scaggiante; Marzia Franzetti; Massimo Andreoni; Giorgio Palù; Anna Maria Cattelan
Journal:  Med Microbiol Immunol       Date:  2017-09-01       Impact factor: 3.402

3.  Improvements in brain and behavior following eradication of hepatitis C.

Authors:  Taylor Kuhn; Philip Sayegh; Jacob D Jones; Jason Smith; Manoj K Sarma; A Ragin; Elyse J Singer; M Albert Thomas; April D Thames; Steven A Castellon; Charles H Hinkin
Journal:  J Neurovirol       Date:  2017-05-30       Impact factor: 2.643

Review 4.  Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknowns.

Authors:  Ameer Abutaleb; Sarah Kattakuzhy; Shyam Kottilil; Erin O'Connor; Eleanor Wilson
Journal:  J Neurovirol       Date:  2018-10-05       Impact factor: 2.643

5.  High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease.

Authors:  Ditte L Hedegaard; Damien C Tully; Ian A Rowe; Gary M Reynolds; David J Bean; Ke Hu; Christopher Davis; Annika Wilhelm; Colin B Ogilvie; Karen A Power; Alexander W Tarr; Deirdre Kelly; Todd M Allen; Peter Balfe; Jane A McKeating
Journal:  J Hepatol       Date:  2016-08-13       Impact factor: 25.083

Review 6.  Hepatitis C virus infection, and neurological and psychiatric disorders - A review.

Authors:  Lydia Yarlott; Eleanor Heald; Daniel Forton
Journal:  J Adv Res       Date:  2016-09-19       Impact factor: 10.479

7.  Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study.

Authors:  Isak Sundberg; Anders Lannergård; Mia Ramklint; Janet L Cunningham
Journal:  BMC Psychiatry       Date:  2018-05-29       Impact factor: 3.630

8.  Hepatitis C Virus Transmission Clusters in Public Health and Correctional Settings, Wisconsin, USA, 2016-20171.

Authors:  Karli R Hochstatter; Damien C Tully; Karen A Power; Ruth Koepke; Wajiha Z Akhtar; Audrey F Prieve; Thomas Whyte; David J Bean; David W Seal; Todd M Allen; Ryan P Westergaard
Journal:  Emerg Infect Dis       Date:  2021-02       Impact factor: 6.883

Review 9.  Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview.

Authors:  Mohd Suhail; Sayed Sartaj Sohrab; Mohammad Amjad Kamal; Esam Ibraheem Azhar
Journal:  Front Oncol       Date:  2022-07-29       Impact factor: 5.738

10.  Environmental Stability and Infectivity of Hepatitis C Virus (HCV) in Different Human Body Fluids.

Authors:  Stephanie Pfaender; Fabian A Helfritz; Anindya Siddharta; Daniel Todt; Patrick Behrendt; Julia Heyden; Nina Riebesehl; Wiebke Willmann; Joerg Steinmann; Jan Münch; Sandra Ciesek; Eike Steinmann
Journal:  Front Microbiol       Date:  2018-03-27       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.